Evidence map›Paper›PMID 35798681›Full record

ArticleJournal of medical virology2022

The variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021.

Joshua G Petrie, Marisa C Eisenberg, Adam S Lauring, Julie Gilbert, Samantha M Harrison, Peter M DeJonge, Emily T Martin

Erratum issuedAbstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Corrigendum.Journal of medical virology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Joshua G PetrieCenter for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.ORCID 0000-0002-5696-965X
Marisa C EisenbergDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Adam S LauringDepartments of Internal Medicine and Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Julie GilbertDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Samantha M HarrisonDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Peter M DeJongeWisconsin Department of Health Services, Madison, Wisconsin, USA.
Emily T MartinDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

Funding

Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions - COVID-19 Administrative SupplementK01AI141579 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETRIE, JOSHUA GLENN · 2019 to 2023
$634k
CDC HHSNIAID NIH HHS K01 AI141579NIH HHS
6 · The paper itself

Abstract

Accurate estimates of the total burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to inform policy, planning, and response. We sought to quantify SARS-CoV-2 cases, hospitalizations, and deaths by age in Michigan. Coronavirus disease 2019 cases reported to the Michigan Disease Surveillance System were multiplied by age and time-specific adjustment factors to correct for under-detection. Adjustment factors were estimated in a model fit to incidence data and seroprevalence estimates. Age-specific incidence of SARS-CoV-2 hospitalization, death, vaccination, and variant proportions were estimated from publicly available data. We estimated substantial under-detection of infection that varied by age and time. Accounting for under-detection, we estimate the cumulative incidence of infection in Michigan reached 75% by mid-November 2021, and over 87% of Michigan residents were estimated to have had ≥1 vaccination dose and/or previous infection. Comparing pandemic waves, the relative burden among children increased over time. In general, the proportion of cases who were hospitalized or who died decreased over time. Our results highlight the ongoing risk of periods of high SARS-CoV-2 incidence despite widespread prior infection and vaccination. This underscores the need for long-term planning for surveillance, vaccination, and other mitigation measures amidst continued response to the acute pandemic.

Indexed as

COVID-19SARS-CoV-2ChildHumansMichiganPandemicsSeroepidemiologic Studiescase fatalityCOVID-19incidenceinfectionSARS-CoV-2seroprevalence

Identifiers

PMID35798681
PMCPMC9350192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.